Development of a Recombinant Vaccine to Prevent Influenza Virus Infection

Loso Judijanto (1), Aung Myint (2), Nandar Hlaing (3), Muntasir Muntasir (4)
(1) IPOSS Jakarta, Indonesia,
(2) University of Yangon, Myanmar,
(3) Mandalay University, Myanmar,
(4) Universitas Nusa Cendans, Indonesia

Abstract

Influenza virus remains a significant global health challenge, causing seasonal epidemics and potential pandemics with high morbidity and mortality rates. This study aims to develop a recombinant vaccine as a safer and more effective alternative to traditional influenza vaccines, which often suffer from limited efficacy and lengthy production timelines. Utilizing a recombinant DNA technology approach, this research employed the baculovirus expression system to produce hemagglutinin (HA) antigens derived from the influenza A virus. Experimental methods included antigen purification, immunogenicity assays in murine models, and neutralizing antibody titration. Results revealed that the recombinant HA vaccine elicited a robust immune response, with a significant increase in hemagglutination inhibition titers compared to control groups. Furthermore, the vaccinated subjects exhibited substantial protection against viral challenge, evidenced by reduced viral load and minimized lung pathology. The findings suggest that recombinant vaccine platforms offer promising avenues for rapid and scalable vaccine development. This study underscores the potential of recombinant influenza vaccines in mitigating future influenza outbreaks with improved safety, efficacy, and production agility.

Full text article

Generated from XML file

References

Anastassopoulou, C., Panagiotopoulos, A.-P., Siafakas, N., & Tsakris, A. (2025). The potential of RNA-binding proteins as host-targeting antivirals against RNA viruses. International Journal of Antimicrobial Agents, 66(2). Scopus. https://doi.org/10.1016/j.ijantimicag.2025.107522

Babbar, R., Kaur, J., Kaur, K., Vagh, V. D., Sachdeva, M., Behl, T., Gulati, M., & Gasmi, A. (2025). Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment. Current Drug Targets. Scopus. https://doi.org/10.2174/0113894501336800250220051811

Bardach, A., Brizuela, M., Berrueta, M., Ciapponi, A., Sambade, J. M., Ballivian, J., Ortega, V., Castellana, N., Comandé, D., Parker, E. P. K., Kampmann, B., Stegelmann, K., Xiong, X., Stergachis, A., Munoz, F. M., Buekens, P., & Mazzoni, A. (2025). Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines. Human Vaccines and Immunotherapeutics, 21(1). Scopus. https://doi.org/10.1080/21645515.2025.2463191

Chen, X., Kong, M., Ma, C., Zhang, M., Hu, Z., Gu, M., Wang, X., Gao, R., Hu, S., Chen, Y., Liu, X., Peng, D., Liu, X., & Hu, J. (2025). The PA-X host shutoff site 100 V exerts a contrary effect on viral fitness of the highly pathogenic H7N9 influenza A virus in mice and chickens. Virulence, 16(1). Scopus. https://doi.org/10.1080/21505594.2024.2445238

Cheng, X., Zeng, T., Xu, Y., & Xiong, Y. (2025). The emerging role of PANoptosis in viral infections disease. Cellular Signalling, 125. Scopus. https://doi.org/10.1016/j.cellsig.2024.111497

Chu, X., Chen, J., Lin, L., Yao, J., Huang, L., Gao, M., Shen, J., & Pan, X. (2025). Temporal Dynamics of Immune Response Signalling in Largemouth Bass (Micropterus salmoides) Infected With Largemouth Bass Virus. Journal of Fish Diseases, 48(5). Scopus. https://doi.org/10.1111/jfd.14086

Desheva, Y. A., Shvedova, T. N., Kopteva, O. S., Guzenkov, D. S., Kudar, P. A., Kotomina, T. S., Petrachkova, D. S., Grigorieva, E. P., Lerner, A. A., & Ponkratov, S. V. (2025). The Clinical and Laboratory Landscape of COVID-19 During the Initial Period of the Pandemic and at the Beginning of the Omicron Era. Viruses, 17(4). Scopus. https://doi.org/10.3390/v17040481

Eskenazi, B., Rauch, S., Elsiwi, B., Bornman, R., Obida, M., Brewer, A., Ward, B. J., & Chevrier, J. (2025). Undernutrition and antibody response to measles, tetanus and Haemophilus Influenzae type b (Hib) vaccination in pre-school south African children: The VHEMBE birth cohort study. Vaccine, 46. Scopus. https://doi.org/10.1016/j.vaccine.2024.126564

Fang, W., Yoo, D., Li, W., & Vu, H. (2025). Toward a better understanding of genetic diversity and more effective control strategies of major swine viral diseases. Virology, 606. Scopus. https://doi.org/10.1016/j.virol.2025.110480

Faustini, S. E., Backhouse, C., Duggal, N. A., Toellner, K.-M., Harvey, R., Drayson, M. T., Lord, J. M., & Richter, A. G. (2025). Time of day of vaccination does not influence antibody responses to pneumococcal and annual influenza vaccination in a cohort of healthy older adults. Vaccine, 49. Scopus. https://doi.org/10.1016/j.vaccine.2025.126770

Firdaus, M. E. R., Dukhno, E., Kapoor, R., & Gerlach, P. (2025). Two Birds With One Stone: RNA Virus Strategies to Manipulate G3BP1 and Other Stress Granule Components. Wiley Interdisciplinary Reviews: RNA, 16(2). Scopus. https://doi.org/10.1002/wrna.70005

Galindo-Méndez, M., Galindo-Ruiz, M., Concheso-Venegas, M. F., Mendoza-Molina, S. U., Orozco-Cruz, D., & Weintraub-Benzion, E. (2025). The Impact of Vitamin D in the Prevention of Influenza, COVID-19, and Dengue: A Review. Biomedicines, 13(4). Scopus. https://doi.org/10.3390/biomedicines13040927

Gong, Z., Hu, M., Zhao, G., Liang, N., Zhang, H., Li, H., Che, Q., Guo, J., Song, T., Wang, Y., Shi, N., & Liu, B. (2025). Therapeutic Effects of Alkaloids on Influenza: A Systematic Review and Meta-Analysis of Preclinical Studies. International Journal of Molecular Sciences, 26(5). Scopus. https://doi.org/10.3390/ijms26051823

Good, M. R., Suja, D., & Guthmiller, J. J. (2025). The sweet side of H5N1 influenza virus infection. PLoS Pathogens, 21(1). Scopus. https://doi.org/10.1371/journal.ppat.1012847

Grycová, A., Vyhlídalová, B., & Dvo?ák, Z. (2025). The role of aryl hydrocarbon receptor in antiviral immunity: A focus on RNA viruses. Critical Reviews in Microbiology. Scopus. https://doi.org/10.1080/1040841X.2025.2497789

Guo, M., Chen, S., Gao, W., Dong, L., & Yao, K. (2025). The unusual surge and patterns of scarlet fever in China warrant close monitoring. Journal of Infection, 90(1). Scopus. https://doi.org/10.1016/j.jinf.2024.106381

Javanshir, N., Ebrahimi, V., Mazhary, Z., Saadaie Jahromi, B., Zuo, T., & Fard, N. A. (2025). The antiviral effects and underlying mechanisms of probiotics on viral infections. Microbial Pathogenesis, 200. Scopus. https://doi.org/10.1016/j.micpath.2025.107377

Kierbied?-Guzik, N., & Soza?ska, B. (2025). The Molecular Basis of Asthma Exacerbations Triggered by Viral Infections: The Role of Specific miRNAs. International Journal of Molecular Sciences, 26(1). Scopus. https://doi.org/10.3390/ijms26010120

Lawrenz, J., Wettstein, L., Rodríguez Alfonso, A., Nchioua, R., von Maltitz, P., Albers, D. P. J., Zech, F., Vandeput, J., Naesens, L., Fois, G., Neubauer, V., Preising, N., Schmierer, E., Almeida-Hernandez, Y., Petersen, M., Ständker, L., Wiese, S., Braubach, P., Frick, M., … Münch, J. (2025). Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum Efficacy against Corona and Influenza Viruses. Advanced Science. Scopus. https://doi.org/10.1002/advs.202506430

Laybourn, H. A., Kristensen, C., Pedersen, A. G., Brogaard, L., George, S., Henriksen, B. L., Polhaus, C. H., Trebbien, R., Larsen, L. E., & Skovgaard, K. (2025). Tracking mucosal innate immune responses to three influenza A virus strains in a highly translational pig model using nasopharyngeal swabs. Innate Immunity, 31, 17534259251331385. Scopus. https://doi.org/10.1177/17534259251331385

Levintow, S. N., Remch, M., Jones, E. P., Lessler, J., Edwards, J. K., Brinkley-Rubinstein, L., Rice, D. K., Rosen, D. L., & Powers, K. A. (2025). Transmission models of respiratory infections in carceral settings: A systematic review. Epidemics, 50. Scopus. https://doi.org/10.1016/j.epidem.2024.100809

Li, Y., Yang, H. S., Klasse, P. J., & Zhao, Z. (2025). The significance of antigen-antibody-binding avidity in clinical diagnosis. Critical Reviews in Clinical Laboratory Sciences, 62(1), 9–23. Scopus. https://doi.org/10.1080/10408363.2024.2379286

Luo, J., Lu, Y., Dai, E., Yin, N., Wang, T., Qian, H., Jiang, Q., Cao, X., Wang, C., & Zeng, Y. (2025). The PB1 protein of H9N2 influenza A virus inhibits antiviral innate immunity by targeting MAVS for TRIM25-mediated autophagic degradation. Poultry Science, 104(1). Scopus. https://doi.org/10.1016/j.psj.2024.104639

Manivasagam, S., Han, J., Teghanemt, A., Keen, H., Sownthirarajan, B., Cheng, B., Singh, A., Lewis, A., Vogel, O. A., Loganathan, G., Huang, L., Panis, M., Meyerholz, D. K., tenOever, B., Perez, J. T., Manicassamy, S., Issuree, P. D., & Manicassamy, B. (2025). Transcriptional repressor Capicua is a gatekeeper of cell-intrinsic interferon responses. Cell Host and Microbe, 33(4), 512-528.e7. Scopus. https://doi.org/10.1016/j.chom.2025.02.017

Osman, M. K., Robert, J., Broich, L., Frank, D., Grosse, R., Schwemmle, M., Wrobel, A. G., Ciminski, K., Sieben, C., & Reuther, P. (2025). The bat influenza A virus subtype H18N11 induces nanoscale MHCII clustering upon host cell attachment. Nature Communications, 16(1). Scopus. https://doi.org/10.1038/s41467-025-58834-y

Paczkowska, A., Hoffmann, K., Andrzejczak, A., Pucek, W. F., Kopciuch, D., Bryl, W., Nowakowska, E., & Kus, K. (2025). The Application of mRNA Technology for Vaccine Production—Current State of Knowledge. Vaccines, 13(4). Scopus. https://doi.org/10.3390/vaccines13040389

Pan, X., Zhou, F., Shi, X., Liu, Q., Yan, D., Teng, Q., Yuan, C., Xu, B., Zhang, Z., Yan, M., & Li, Z. (2025). The Generation of a H9N2 Avian Influenza Virus with HA and C3d-P29 Protein Fusions and Vaccine Development Applications. Vaccines, 13(2). Scopus. https://doi.org/10.3390/vaccines13020099

Park, J. Y., Choi, S.-H., Lim, Y. K., Shin, J., Kwon, S., Kim, H., & Chung, J.-W. (2025). The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients. Vaccines, 13(2). Scopus. https://doi.org/10.3390/vaccines13020170

Park, S., Yi, E., Jeon, J., Oh, J., Xu, Z., & Park, S.-H. (2025). The Role of Bone Marrow Stromal Cell Antigen 2 (BST2) in the Migration of Dendritic Cells to Lymph Nodes. International Journal of Molecular Sciences, 26(1). Scopus. https://doi.org/10.3390/ijms26010149

Pei, T., Li, W., Zhou, Z., Zhang, Q., Yu, G., Yin, S., Chen, H., & Tang, J. (2025). The relationship between tryptophan metabolism and gut microbiota: Interaction mechanism and potential effects in infection treatment. Microbiological Research, 298. Scopus. https://doi.org/10.1016/j.micres.2025.128211

Pu, Z., Ma, Y., Chen, X., Liu, Y., Fang, Z., Peng, Y., & Li, X. (2025). Total saponins from Siraitiae Fructus alleviate lung and intestinal injuries in rats with acute lung injury and mice infected with the influenza virus by regulating cytokines and enhancing the mucosal barrier. Food Bioscience, 68. Scopus. https://doi.org/10.1016/j.fbio.2025.106538

Puggina, A., Rumi, F., Zarkadoulas, E., Marijam, A., & Calabró, G. E. (2025). The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in Italy. Vaccines, 13(3). Scopus. https://doi.org/10.3390/vaccines13030212

Shurygina, A.-P., Shuklina, M., Ozhereleva, O., Romanovskaya-Romanko, E., Kovaleva, S., Egorov, A., Lioznov, D., & Stukova, M. (2025). Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice. Vaccines, 13(1). Scopus. https://doi.org/10.3390/vaccines13010058

Smatti, M. K., Yassine, H. M., Mbarek, H., & Boomsma, D. I. (2025). Understanding Heritable Variation Among Hosts in Infectious Diseases Through the Lens of Twin Studies. Genes, 16(2). Scopus. https://doi.org/10.3390/genes16020177

Tan, K. S., Liu, J., Andiappan, A. K., Lew, Z. Z. R., He, T. T., Ong, H. H., Tay, D. J. W., Aw, Z. Q., Yi, B., Fauzi, A. M., Yogarajah, T., Carmen, L. C. P., Chu, J. J. H., Chow, V. T., Prabakaran, M., & Wang, D.-Y. (2025). Unique immune and other responses of human nasal epithelial cells infected with H5N1 avian influenza virus compared to seasonal human influenza A and B viruses. Emerging Microbes and Infections, 14(1). Scopus. https://doi.org/10.1080/22221751.2025.2484330

Vu, T. H., Kim, C., Truong, A. D., Kim, J.-M., Lillehoj, H. S., & Hong, Y. H. (2025). Unveiling the role of long non-coding RNAs in chicken immune response to highly pathogenic avian influenza H5N1 infection. Poultry Science, 104(1). Scopus. https://doi.org/10.1016/j.psj.2024.104524

Vu, T. H., Kim, C., Truong, A. D., Lillehoj, H. S., & Hong, Y. H. (2025). Unveiling the immunomodulatory role of soluble chicken fractalkine: Insights from functional characterization and pathway activation analyses. Developmental and Comparative Immunology, 162. Scopus. https://doi.org/10.1016/j.dci.2024.105279

Wei, C., Xu, Y., Zheng, Y., Hong, L., Lyu, C., Li, H., & Cao, B. (2025). The LTB4-BLT1 axis attenuates influenza-induced lung inflammation by suppressing NLRP3 activation. Cell Death Discovery, 11(1). Scopus. https://doi.org/10.1038/s41420-025-02450-8

Xie, S., Wei, J., & Wang, X. (2025). The intersection of influenza infection and autoimmunity. Frontiers in Immunology, 16. Scopus. https://doi.org/10.3389/fimmu.2025.1558386

Yang, Q., Guo, H., Li, H., Li, Z., Ni, F., Wen, Z., Liu, K., Kong, H., & Wei, W. (2025). The CXCL8/MAPK/hnRNP-K axis enables susceptibility to infection by EV-D68, rhinovirus, and influenza virus in vitro. Nature Communications, 16(1). Scopus. https://doi.org/10.1038/s41467-025-57094-0

Zhang, Y., Lv, Y., Chen, X., Ye, Y., Yu, S., Li, N., Yao, H., Wang, Z., Feng, Q., Wu, R., & Li, L. S. (2025). Ultrasensitive point-of-care multiplex diagnosis for influenza virus based robust quantum dot microsphere-lateral flow immunoassay. Biosensors and Bioelectronics, 273. Scopus. https://doi.org/10.1016/j.bios.2025.117187

Zhao, Q., Pan, P., Mo, L., Wu, J., Liao, S., Lu, H., Zhang, Q., & Zhang, X. (2025). The ELF3-TRIM22-MAVS signaling axis regulates type I interferon and antiviral responses. Journal of Virology, 99(5), e0000425. Scopus. https://doi.org/10.1128/jvi.00004-25

Authors

Loso Judijanto
losojudijantobumn@gmail.com (Primary Contact)
Aung Myint
Nandar Hlaing
Muntasir Muntasir
Judijanto, L., Myint, A., Hlaing, N., & Muntasir, M. (2025). Development of a Recombinant Vaccine to Prevent Influenza Virus Infection. Journal of Biomedical and Techno Nanomaterials, 2(2), 80–91. https://doi.org/10.70177/jbtn.v2i2.2025

Article Details

Similar Articles

You may also start an advanced similarity search for this article.